CN107325814B - A kind of fluorescence silicon nano dots and the preparation method and application thereof - Google Patents
A kind of fluorescence silicon nano dots and the preparation method and application thereof Download PDFInfo
- Publication number
- CN107325814B CN107325814B CN201710478865.2A CN201710478865A CN107325814B CN 107325814 B CN107325814 B CN 107325814B CN 201710478865 A CN201710478865 A CN 201710478865A CN 107325814 B CN107325814 B CN 107325814B
- Authority
- CN
- China
- Prior art keywords
- sinds
- imaging
- fluorescent
- lysosome
- fluorescence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 title claims abstract description 29
- 229910052710 silicon Inorganic materials 0.000 title claims abstract description 29
- 239000010703 silicon Substances 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title description 11
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229910000077 silane Inorganic materials 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract 3
- 230000002132 lysosomal effect Effects 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 19
- 239000002096 quantum dot Substances 0.000 claims description 19
- 239000007850 fluorescent dye Substances 0.000 claims description 14
- IICCLYANAQEHCI-UHFFFAOYSA-N 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodospiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O1C(=O)C(C(=C(Cl)C(Cl)=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 IICCLYANAQEHCI-UHFFFAOYSA-N 0.000 claims description 11
- 238000006243 chemical reaction Methods 0.000 claims description 11
- 229930187593 rose bengal Natural products 0.000 claims description 11
- 229940081623 rose bengal Drugs 0.000 claims description 11
- STRXNPAVPKGJQR-UHFFFAOYSA-N rose bengal A Natural products O1C(=O)C(C(=CC=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 STRXNPAVPKGJQR-UHFFFAOYSA-N 0.000 claims description 11
- 239000000243 solution Substances 0.000 claims description 11
- 238000000502 dialysis Methods 0.000 claims description 4
- NHBRUUFBSBSTHM-UHFFFAOYSA-N n'-[2-(3-trimethoxysilylpropylamino)ethyl]ethane-1,2-diamine Chemical compound CO[Si](OC)(OC)CCCNCCNCCN NHBRUUFBSBSTHM-UHFFFAOYSA-N 0.000 claims description 4
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 claims description 3
- SJECZPVISLOESU-UHFFFAOYSA-N 3-trimethoxysilylpropan-1-amine Chemical group CO[Si](OC)(OC)CCCN SJECZPVISLOESU-UHFFFAOYSA-N 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 2
- PHQOGHDTIVQXHL-UHFFFAOYSA-N n'-(3-trimethoxysilylpropyl)ethane-1,2-diamine Chemical compound CO[Si](OC)(OC)CCCNCCN PHQOGHDTIVQXHL-UHFFFAOYSA-N 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- BPSIOYPQMFLKFR-UHFFFAOYSA-N trimethoxy-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CO[Si](OC)(OC)CCCOCC1CO1 BPSIOYPQMFLKFR-UHFFFAOYSA-N 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 abstract description 54
- 210000003712 lysosome Anatomy 0.000 abstract description 53
- 230000001868 lysosomic effect Effects 0.000 abstract description 53
- 238000003384 imaging method Methods 0.000 abstract description 50
- 230000000694 effects Effects 0.000 abstract description 24
- 239000000523 sample Substances 0.000 abstract description 10
- 230000008823 permeabilization Effects 0.000 abstract description 8
- 230000008901 benefit Effects 0.000 abstract description 6
- 238000006862 quantum yield reaction Methods 0.000 abstract description 5
- 238000001027 hydrothermal synthesis Methods 0.000 abstract description 4
- 206010034972 Photosensitivity reaction Diseases 0.000 abstract description 2
- 208000007578 phototoxic dermatitis Diseases 0.000 abstract description 2
- 231100000018 phototoxicity Toxicity 0.000 abstract description 2
- 238000004140 cleaning Methods 0.000 abstract 2
- 240000008254 Rosa chinensis Species 0.000 abstract 1
- 235000000664 Rosa chinensis Nutrition 0.000 abstract 1
- 210000004962 mammalian cell Anatomy 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- AZJPTIGZZTZIDR-UHFFFAOYSA-L rose bengal Chemical compound [K+].[K+].[O-]C(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 AZJPTIGZZTZIDR-UHFFFAOYSA-L 0.000 abstract 1
- 238000010189 synthetic method Methods 0.000 abstract 1
- 238000004113 cell culture Methods 0.000 description 8
- 239000000975 dye Substances 0.000 description 8
- 230000005284 excitation Effects 0.000 description 8
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 7
- 239000002953 phosphate buffered saline Substances 0.000 description 7
- 238000010186 staining Methods 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- HXMVNCMPQGPRLN-UHFFFAOYSA-N 2-hydroxyputrescine Chemical compound NCCC(O)CN HXMVNCMPQGPRLN-UHFFFAOYSA-N 0.000 description 6
- 231100000135 cytotoxicity Toxicity 0.000 description 5
- 230000003013 cytotoxicity Effects 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 239000002086 nanomaterial Substances 0.000 description 5
- 239000002105 nanoparticle Substances 0.000 description 5
- 230000008045 co-localization Effects 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 230000008685 targeting Effects 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 239000008055 phosphate buffer solution Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000004065 semiconductor Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000004940 nucleus Anatomy 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- LXQOQPGNCGEELI-UHFFFAOYSA-N 2,4-dinitroaniline Chemical compound NC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O LXQOQPGNCGEELI-UHFFFAOYSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical class [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000004900 autophagic degradation Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- UHYPYGJEEGLRJD-UHFFFAOYSA-N cadmium(2+);selenium(2-) Chemical compound [Se-2].[Cd+2] UHYPYGJEEGLRJD-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000031154 cholesterol homeostasis Effects 0.000 description 1
- 230000003436 cytoskeletal effect Effects 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000695 excitation spectrum Methods 0.000 description 1
- 238000002284 excitation--emission spectrum Methods 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000031146 intracellular signal transduction Effects 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 229940056932 lead sulfide Drugs 0.000 description 1
- 229910052981 lead sulfide Inorganic materials 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 210000005265 lung cell Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- PGSADBUBUOPOJS-UHFFFAOYSA-N neutral red Chemical compound Cl.C1=C(C)C(N)=CC2=NC3=CC(N(C)C)=CC=C3N=C21 PGSADBUBUOPOJS-UHFFFAOYSA-N 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 210000000633 nuclear envelope Anatomy 0.000 description 1
- 238000012758 nuclear staining Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 150000003141 primary amines Chemical group 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000012128 staining reagent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000007838 tissue remodeling Effects 0.000 description 1
- 238000004627 transmission electron microscopy Methods 0.000 description 1
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
- C09K11/59—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing silicon
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y20/00—Nanooptics, e.g. quantum optics or photonic crystals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
- G01N21/6458—Fluorescence microscopy
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Inorganic Chemistry (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Manufacturing & Machinery (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
The invention discloses a kind of fluorescence silicon nano dots (SiNDs), it is prepared by silane and Bengal rose red with one step of hydro-thermal method.Compared with prior art, the SiNDs prepared by the present invention has the fluorescence quantum yield (100%) of superelevation, and can realize the long-time specific imaging to mammalian cell lysosome.In addition, the lysosome imaging effect of the SiNDs is not influenced by cell cleaning, fixed and permeabilization etc., have the advantages that resistance to cleaning, resistance to fixation and resistance to permeabilization.Meanwhile the SiNDs also has the advantages that manufacturing cost is low, synthetic method is simple, water dispersible is good, fluorescence emission peak width, good light stability, cell compatibility is good, cell phototoxicity is low etc., is expected to become novel lysosome fluorescence probe.
Description
Technical Field
The invention belongs to the field of nano materials and biotechnology, and particularly relates to a fluorescent silicon nanodot as well as a preparation method and application thereof.
Background
Fluorescent materials have a wide range of applications in biomedicine. Compared with the traditional organic fluorescent small molecules, the fluorescent nano material has the advantages of better light stability, adjustable excitation emission wavelength and the like, and is widely concerned in recent years. There are many kinds of existing fluorescent nano materials, but they all have certain disadvantages, such as: traditional semiconductor quantum dots (such as cadmium selenide, lead sulfide and the like) generally contain heavy metal elements with high toxicity, so the dosage of the traditional semiconductor quantum dots in biomedicine is greatly limited; although the biocompatibility of the noble metal nano-cluster (such as gold nano-cluster and silver nano-cluster) and the up-conversion nano-particles is better than that of semiconductor quantum dots, the quantum yield is generally lower, and the imaging effect is poor; the synthesis method of the polymer quantum dots is complex, and the surface modification of the polymer quantum dots can greatly influence the fluorescence property of the polymer quantum dots; the carbon dots and the graphene quantum dots have wide fluorescence emission peaks, have multicolor luminescence property and are not beneficial to being used with other probes; other novel nano-dots (such as black phosphorus quantum dots) have the problems of difficult surface modification, harsh preparation conditions and the like. Therefore, the development of the super-bright fluorescent nano material with excellent performance and meeting the biomedical significance is of great significance.
Lysosomes, on the other hand, are key organelles in eukaryotic cells, are single-layer membrane-coated vesicular structures, contain a variety of acid hydrolases, and can decompose and digest a variety of exogenous and endogenous molecules and substances in cells, and are the digestion centers of the cells. Lysosomes also play an important role in a range of physiological processes including apoptosis, autophagy, intracellular cholesterol homeostasis, plasma membrane repair, cytoskeletal and tissue remodeling, pathogen defense, and intracellular signal transduction. Therefore, the observation and tracking of the number, size, morphology, etc. of lysosomes is very important for understanding the behavior and fate of cells. Lysosomes are acidic in vivo (pH 4.5-5.0) compared to other organelles, and therefore lysosomal imaging is often achieved using molecules capable of targeting an acidic environment. For example, 3- (2, 4-dinitroaniline) -3' -amino-N-methyldipropylamine (DAMP) is a commonly used lysosomal targeting molecule, but because the molecule is not fluorescent by itself, grafting a fluorescent molecule onto the primary amine group of the molecule is required to achieve lysosomal imaging. Some fluorescent molecules (e.g., neutral red and acridine orange), while capable of imaging lysosomes, also image nucleic acids that are acidic in the nucleus. Currently, commercial lysosomal fluorescent probes (such as LysoTracker series dyes from Thermo Fisher) have a good lysosomal imaging effect, but have the disadvantages of high synthesis cost, poor light stability and short lysosomal imaging time. Meanwhile, the surface of the fluorescent probe has no modifying group, so that the fluorescent probe cannot be further modified and applied. Emerging fluorescent nanomaterials are considered to be effective approaches to solve the above problems. For example, organic fluorescent nanoparticles (PVP and BPVP) prepared by Lin et al target lysosomes of cancer cells, but do not enable lysosomal imaging of normal cells (org.biomol.chem.,2009,7,2036.). After the surface of gold nanoparticles is modified by a fluorescent molecule FITC and a polypeptide capable of targeting lysosomes, Dekiwadia et al realize imaging of lysosomes (J.Pept.Sci.,2012,18,527.). None of the above methods, however, evaluated the effect of nanoparticles on imaging lysosomes in cells after immobilization and permeabilization. In addition, long-term real-time observation of lysosomal behavior has an important role in studying physiological changes of cells, and none of the above methods can achieve long-term imaging of lysosomes of living cells. Therefore, the development of a fluorescent nanoparticle with good performance as a fluorescent probe for long-time lysosome observation is urgently needed to realize long-time imaging of the lysosome of living cells and imaging of the lysosome of fixed and permeabilized cells.
Disclosure of Invention
The invention aims to provide fluorescent silicon nanodots (SiNDs) to realize lysosome imaging with ultra-long time, washing resistance, fixation resistance and permeabilization resistance, and solve the problems of high cost, poor stability, short imaging time and the like in the prior art.
The invention also aims to solve the technical problem of providing a preparation method and application of the fluorescent silicon nanodot.
In order to solve the technical problems, the technical scheme adopted by the invention is as follows:
a fluorescent silicon nanodot comprises the following components in parts by weight:
100 parts of water-soluble silane;
1-10 parts of rose bengal.
Wherein, the following components in parts by weight are preferred:
100 parts of water-soluble silane;
rose bengal 3 parts.
Wherein the water-soluble silane is Aminopropyltrimethoxysilane (APTMS), Aminopropyltriethoxysilane (APTES), 3- (2-aminoethylamino) propyltrimethoxysilane (DAMO), 3- [2- (2-aminoethylamino) ethylamino ] propyltrimethoxysilane (AEEA) or gamma-Glycidoxypropyltrimethoxysilane (GPTMS), preferably 3- [2- (2-aminoethylamino) ethylamino ] propyltrimethoxysilane (AEEA).
The preparation method of the fluorescent silicon nanodot comprises the following steps:
dissolving rose bengal in the formula amount in ultrapure water, adding water-soluble silane in the formula amount, and reacting; and after the reaction is finished, dialyzing the reaction solution cooled to room temperature to obtain the fluorescent silicon nanodot aqueous solution.
Wherein,
the reaction temperature is 120-250 ℃, and preferably 160 ℃;
the reaction time is 2-24 h, preferably 3 h;
the reaction device is preferably a hydrothermal reaction kettle.
Wherein the cut-off molecular weight of the dialysis bag used for dialysis is 500-1000.
The application of the fluorescent silicon nanodots as the lysosome fluorescent probe is also within the protection scope of the invention.
The application of the rose bengal in preparing the fluorescent silicon nanodots is also within the protection scope of the invention; the preparation of the fluorescent silicon nanodots is performed by the method described above with reference to a water-soluble silane (preferably 3- [2- (2-aminoethylamino) ethylamino ] propyltrimethoxysilane).
In the invention, the rose bengal is not only used as a coloring agent, but also participates in the synthesis of the fluorescent silicon dots, has an important effect on the synthesis of the fluorescent silicon dots, and cannot be replaced by other coloring agents.
Has the advantages that:
compared with the prior art, the invention has the following advantages:
(1) ultra-high fluorescence quantum yield: the quantum yield of the fluorescent silicon nano-dot can reach 100%, and an excellent lysosome imaging effect can be obtained only with the sample concentration of 20 mu g/mL;
(2) excellent lysosome specific targeting: the co-localization rate with the commercial lysosomal probe is more than 98 percent, and the probe is only present in lysosomes even if the probe is incubated with cells for a long time;
(3) can realize the imaging of the lysosome for a very long time: after the probe is incubated with cells and washed by phosphate buffer solution, the probe still has a good lysosome imaging effect within 48 hours, and the commercialized lysosome probe only has a good lysosome imaging effect within 2 hours;
(4) has excellent photobleaching resistance: the silicon nanodots are not easily photobleached under laser irradiation, and the light stability of the silicon nanodots is better than that of commercial lysosomal dyes, so that long-time continuous imaging observation can be realized;
(5) has good washing resistance, fixation resistance and permeabilization resistance: after cells are washed, fixed and permeabilized for many times, the silicon nanodots can still have a good imaging effect on lysosomes;
(6) has better biocompatibility: the silicon nanodots have low toxicity to cells at a concentration of 500 [ mu ] g/mL or less through cytotoxicity evaluation experiments; after long-time irradiation by laser, the cytotoxicity is still very low, which proves that the material has good biocompatibility and lower phototoxicity;
(7) the preparation method is simple, the raw materials are cheap and easy to obtain, and the mass preparation can be realized.
Drawings
FIG. 1 is a schematic representation of the preparation of ultra-bright fluorescent silicon nanodots (SiNDs) using silane reagents AEEA and rose bengal in example 1;
FIG. 2 is a transmission electron microscope photograph of SiNDs obtained in example 1;
FIG. 3 is a graph showing the statistical results of particle sizes of SiNDs produced in example 1;
FIG. 4 is a graph showing UV-VIS absorption spectra of SiNDs obtained in example 1;
FIG. 5 is a graph showing fluorescence excitation and emission spectra of SiNDs obtained in example 1;
FIG. 6 is a graph showing extinction at 650nm in various pH environments for SiNDs obtained in example 1;
FIG. 7 is a graph showing the imaging effect of lysosomes by SiNDs prepared in example 1 after incubation in A549 cells for various periods of time;
FIG. 8 is a graph of the imaging effect of lysosome after incubation of commercial Green lysosomal fluorescent dye LysoTracker Green (LT-Green) with A549 cells for various periods of time;
FIG. 9 is a graph of the effect of imaging lysosomes with the commercial Red lysosomal fluorescent dye LysoTracker Red (LT-Red) after incubation with A549 cells for various periods of time;
FIG. 10 is a graph comparing imaging effects of SiNDs prepared in example 1 with lysosomes from LT-Green and LT-Red after rinsing for various periods of time;
FIG. 11 is a graph comparing the fluorescence stability of SiNDs and LT-Red obtained in example 1 after being irradiated with laser light for various periods of time;
FIG. 12 is a graph comparing the effects of immobilization and permeabilization resistance of the SiNDs prepared in example 1 with LT-Green and LT-Red in A549 cells;
FIG. 13 is a graph showing imaging effects of lysosomes from SiNDs obtained in example 1 in different cell lines;
FIG. 14 is a graph showing cytotoxicity of SiNDs prepared in example 1 in A549 cells under light and normal conditions.
Detailed Description
Example 1
Taking AEEA as an example, the preparation of the fluorescent silicon nanodots comprises the following steps:
(1) rose bengal is weighed and dissolved well in ultrapure water, and the appropriate volume of AEEA is added so that the mass ratio of AEEA to rose bengal is 100: 3. fully and uniformly mixing the two and transferring the mixture into a hydrothermal reaction kettle;
(2) reaction: reacting for 3 hours at 160 ℃ in a hydrothermal reaction kettle to form a silicon nano-dot solution;
(3) and (3) purification: dialyzing to obtain the target ultra-bright fluorescent silicon nano-dot solution.
The reaction is schematically shown in FIG. 1, and the transmission electron microscopy results of the prepared SiNDs are shown in FIG. 2, the statistical results of the particle size distribution are shown in FIG. 3, the ultraviolet-visible absorption spectrum is shown in FIG. 4, the fluorescence excitation emission spectrum is shown in FIG. 5, and the extinction degrees at 650nm in different pH environments are shown in FIG. 6. As can be seen from the above figures, the prepared SiNDs are in the shape of uniform spheres, the particle size is approximately 2.5nm, the maximum ultraviolet absorption peak is located at 511nm, and the maximum excitation wavelength and the maximum emission wavelength are 511nm and 525nm respectively. The fluorescence quantum yield of the SiNDs can reach 100 percent through calculation. In particular, as can be seen from fig. 6, SiNDs are easy to aggregate and precipitate under the condition of weak acid environment, and the characteristic causes particle aggregation when entering acid lysosomes in cells, thereby realizing long-time lysosome imaging.
Example 2
The imaging effect of SiNDs prepared in example 1 on lysosomes of a549 cells was tested by the following method:
(1) cell culture: a549 cells at 5X 103Density of cells/well 96-well plates were seeded at 37 ℃ with 5% CO2Culturing for 24h in the environment;
(2) cell staining: the culture medium in each well was replaced with fresh culture medium containing 20 g/mL SiNDs at 37 deg.C with 5% CO2After incubation for 2,4, 18 and 24h in ambient, respectively, washing was performed 2 times with Phosphate Buffered Saline (PBS). Then, staining was performed with a commercial Red lysosomal fluorescent dye (LT-Red) and a nuclear staining reagent (Hoechst 33342) for 30 and 10 minutes, respectively. Finally, the cells were washed 2 times with PBS;
(3) and (3) confocal fluorescence microscope imaging observation: laser with the wavelength of 405, 488 and 552nm is used as exciting light, Hoechst 33342 dye emits blue fluorescence under the excitation of 405nm exciting light, SiNDs emits green fluorescence under the excitation of 488nm exciting light, and LT-Red dye emits Red fluorescence under the excitation of 552nm laser.
Lysosome imaging and co-localization results are shown in figure 7. As can be seen, the SiNDs are mainly distributed at some punctate positions after entering cells, and after the SiNDs are subjected to colocalization analysis with Red commercial lysosome fluorescent dye (LT-Red), the lighted areas of the SiNDs are proved to be lysosomes, and the colocalization rate with the lysosome dye is up to 98% after calculation. In addition, even if the dosing time is extended to 24h, the SiNDs stay in lysosomes. Therefore, the capability of the synthesized SiNDs in the invention to target lysosomes is not different along with the change of dosing time, and the stability of lysosome imaging is reflected.
Examples 3 and 4
Commercial lysosomal Green fluorescent dye (LT-Green) and Red fluorescent dye (LT-Red) were tested for their lysosomal imaging effects on A549 cells.
The procedures of examples 3 and 4 are substantially the same as those of example 1, except that SiNDs in step (2) are replaced by 1LT-Green and LT-Red, and the SiNDs are cultured for 30min, 4h and 8h, respectively.
Lysosomal imaging effects are shown in figures 8 and 9. As can be seen from the observation of FIGS. 8 and 9, the change in the dosing time had little effect on the Green lysosomal fluorescent dye LT-Green, but the LT-Red site was greatly changed. With the addition time extended to 4h, LT-Red was transferred to the cytoplasmic and nuclear membrane regions other than lysosomes, and even at 8h some of the dye had entered the nucleus. Therefore, compared with LT-Red, the synthesized SiNDs are more suitable for long-time tracking lysosome imaging.
Example 5
The imaging stability of the SiNDs prepared in example 1 and commercial LT-Green and LT-Red on washed lysosomes was tested by the following method:
(1) cell culture: the procedure was in accordance with step (1) in example 2;
(2) cell staining and washing: the culture solution in the cell culture wells was changed to fresh culture solution containing SiNDs (20. mu.g/mL), LT-Green (1. mu.M) and LT-Red (1. mu.M), respectively, and the wells were stained for 2h, 30min and 30 min. After washing twice with PBS, the mixture was washed at 37 ℃ with 5% CO2Culturing in dark environment for 0, 1, 2,4, 12, 24, 36 and 48h, and observing under confocal fluorescence microscope;
(3) lysosome imaging effect observation: 488nm and 552nm lasers were used as excitation light. Wherein, SiNDs and LT-Green emit Green fluorescence under 488nm laser, and LT-Red emits Red fluorescence under 552nm laser.
The fluorescence imaging results are shown in FIG. 10. Comparing the imaging results of the three dyes, the fluorescence of the commercial lysosomal dyes LT-Green and LT-Red is obviously weakened within 2h after the cells are washed. Obviously, the SiNDs prepared by the method still have strong fluorescence within 48 hours after the cells are washed, so that the long-time sharp imaging of lysosomes can be realized.
Example 6
The SiNDs prepared in example 1 were tested for their stability in imaging lysosome fluorescence with commercially available LT-Red after exposure to laser light for various periods of time. The method comprises the following steps:
(1) cell culture: the procedure was in accordance with step (1) in example 2;
(2) cell staining: respectively changing the culture solution in the cell culture hole into fresh culture solution containing SiNDs (20 mu g/mL) and LT-Red (1 mu M), staining for 2h and 30min, and washing the cells twice with PBS;
(3) laser irradiation: irradiating the stained cells under 488nm laser for 0, 0.5, 1, 3, 5, 10, 15, 20 and 30min respectively, and observing by using a confocal fluorescence microscope;
(4) and (3) observing fluorescence stability: 488nm and 552nm lasers were used as excitation light. Wherein, SiNDs emit green fluorescence under 488nm laser, and LT-Red emits Red fluorescence under 552nm laser.
As can be seen from FIG. 11, the LT-Red fluorescence is significantly reduced within 3min of laser irradiation, while the SiNDs prepared by the invention still maintain clear lysosome imaging effect after 20min of irradiation. The experiment proves the remarkable advantages of SiNDs in the aspects of photobleaching resistance and stable imaging.
Example 7
SiNDs prepared in example 1 were tested for their ability to withstand immobilization and strike-through with commercially available LT-Green and LT-Red. The method comprises the following steps:
(1) cell culture: the procedure was in accordance with step (1) in example 2;
(2) cell staining: the procedure was identical to that of step (2) in example 5, and fresh culture solutions containing SiNDs (20. mu.g/mL), LT-Green (1. mu.M) and LT-Red (1. mu.M) were stained for 2h, 30min and 30min, respectively. Observing the stained cells under a confocal fluorescence microscope;
(3) cell fixation: placing the stained cells in a phosphate buffer solution containing 4% glutaraldehyde for 30 minutes, washing the cells for 2 times by using PBS (phosphate buffer solution), and observing a lysosome imaging result under a confocal fluorescence microscope;
(4) cell permeabilization: after the cell fixation step, the cells were treated with 0.1% Triton X-100 in phosphate buffer for 10 min, and finally washed 2 times with PBS and observed under a confocal fluorescence microscope. The setup conditions of the confocal fluorescence microscope were the same as in step (3) of example 5.
As can be seen from FIG. 12, both LT-Green and LT-Red are not suitable for imaging lysosomes of immobilized and permeabilized cells, and the lysosome imaging probe prepared by the invention has the capabilities of immobilization resistance and permeabilization resistance.
Example 8
The imaging effect of the SiNDs in different cell lines is tested, the operation steps of the imaging method are approximately the same as those of the imaging method in example 2, only the A549 cells in example 2 need to be replaced by normal lung cells AT II, breast cancer cells MCF-7 and macrophages Raw 264.7 respectively, and the staining time is changed to 2 hours.
FIG. 13 shows that the synthesized SiNDs of the present invention have excellent lysosome imaging ability in different cell lines.
Example 9
The cytotoxicity of SiNDs prepared in example 1 to a549 cells under dark and light conditions was tested by the following procedure:
(1) cell culture: the procedure was in accordance with step (1) in example 2;
(2) SiNDs treatment: respectively changing the culture solution in the cell culture hole into fresh culture solution containing SiNDs with different concentrations, wherein the concentration gradient of the SiNDs is as follows: 0, 50, 100, 200, 500 and 1000. mu.g/mL, 5% CO at 37 ℃2After 24h incubation in the environment. The cells were divided into two groups, one group was exposed to white light for 30min, and the other group was exposed to dark. Subsequently, both groups of cells were plated at 37 ℃ with 5% CO2Culturing for 4h in the environment;
(3) and (3) detecting the activity of the cells: cytotoxicity was detected by MTT method.
The cell viability results are shown in figure 14. As can be seen from the figure, even if the concentration of the SiNDs is as high as 200 mug/mL, the cells in the illuminated group and the non-illuminated group both keep more than 90% of activity, and the low toxicity of the SiNDs synthesized by the invention is reflected, so that the SiNDs become a safe lysosome imaging fluorescent probe.
Claims (7)
1. The fluorescent silicon nanodot is characterized by being prepared from the following raw materials in parts by mass:
100 parts of water-soluble silane;
1-10 parts of rose bengal.
2. The fluorescent silicon nanodot of claim 1, wherein the water soluble silane is aminopropyltrimethoxysilane, aminopropyltriethoxysilane, 3- (2-aminoethylamino) propyltrimethoxysilane, 3- [2- (2-aminoethylamino) ethylamino ] propyltrimethoxysilane or gamma-glycidoxypropyltrimethoxysilane.
3. The method for preparing fluorescent silicon nanodots according to claim 1, comprising the steps of:
dissolving rose bengal with the formula amount in water, and adding water-soluble silane with the formula amount for reaction; and after the reaction is finished, dialyzing the reaction solution cooled to room temperature to obtain the fluorescent silicon nanodot aqueous solution.
4. The method according to claim 3, wherein the reaction temperature is 120 to 250 ℃ and the reaction time is 2 to 24 hours.
5. The method according to claim 3, wherein the cut-off molecular weight of the dialysis bag used in dialysis is 500 to 1000.
6. Use of the fluorescent silicon nanodots of claim 1 as lysosomal fluorescent probes.
7. Application of rose bengal in preparing fluorescent silicon nanodots.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710478865.2A CN107325814B (en) | 2017-06-22 | 2017-06-22 | A kind of fluorescence silicon nano dots and the preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710478865.2A CN107325814B (en) | 2017-06-22 | 2017-06-22 | A kind of fluorescence silicon nano dots and the preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107325814A CN107325814A (en) | 2017-11-07 |
CN107325814B true CN107325814B (en) | 2018-11-09 |
Family
ID=60195623
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710478865.2A Active CN107325814B (en) | 2017-06-22 | 2017-06-22 | A kind of fluorescence silicon nano dots and the preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107325814B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108844937B (en) * | 2018-08-07 | 2020-09-08 | 福建中医药大学 | Water-soluble fluorescent silicon dot and preparation method and application thereof |
CN110031436B (en) * | 2019-04-12 | 2021-04-20 | 济南大学 | Organic silicon fluorescent probe for detecting lipid drops |
CN110174387A (en) * | 2019-06-14 | 2019-08-27 | 郑州大学 | A kind of application of fluorescent carbon point in naturally targeting lysosome |
CN110669514B (en) * | 2019-10-23 | 2022-06-24 | 山东师范大学 | Preparation and application of super-bright fluorescent carbon dots |
CN111647400A (en) * | 2020-06-11 | 2020-09-11 | 吉林大学第一医院 | Preparation method of fluorescent organic silicon nano particles |
CN113174255B (en) * | 2021-04-08 | 2022-07-08 | 华南农业大学 | Preparation method and application of water-soluble green fluorescent silanized carbon dots |
CN114214062A (en) * | 2021-12-23 | 2022-03-22 | 郑州中科生物医学工程技术研究院 | Preparation method of fluorine-doped silicon quantum dots and application of fluorine-doped silicon quantum dots in detection of carmine |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009096669A (en) * | 2007-10-17 | 2009-05-07 | Konica Minolta Medical & Graphic Inc | Silicon quantum dot and biomaterial labeling agent using the same |
CN103896271B (en) * | 2014-04-11 | 2015-06-17 | 武汉大学 | Method for preparing water-soluble fluorescent silicon quantum dots by using hydrothermal process |
CN104003392B (en) * | 2014-05-05 | 2016-01-06 | 东南大学 | 3-(2-aminoethylamino) propyl trimethoxy silicane is preparing the application in superbright fluorescence silicon quantum dot |
CN104016348B (en) * | 2014-05-05 | 2016-03-16 | 东南大学 | Diethylenetriamine base propyl trimethoxy silicane is preparing the application in water-soluble silicon quantum dot |
CN104306984A (en) * | 2014-11-07 | 2015-01-28 | 东南大学 | Application of water-soluble silicon quantum dots as drug carriers |
CN105586035B (en) * | 2016-03-04 | 2017-11-03 | 南开大学 | A kind of preparation method of the water-soluble silicon quantum dot of highlighted bluish-green fluorescence |
CN105777792B (en) * | 2016-04-21 | 2018-08-21 | 东南大学 | A kind of quaternization fluorescence silicon point and the preparation method and application thereof |
CN106190114A (en) * | 2016-07-13 | 2016-12-07 | 中南民族大学 | A kind of hydro-thermal method or microwave method prepare the method for high yield fluorescence silicon quantum dot |
CN106350061B (en) * | 2016-08-29 | 2019-03-29 | 北京化工大学 | A kind of silicon quantum dot and the preparation method and application thereof |
CN106596482B (en) * | 2016-12-08 | 2019-04-30 | 哈尔滨师范大学 | Fluorescence silicon nano particles and its application in mercury ion detecting and fingerprint manifestation |
-
2017
- 2017-06-22 CN CN201710478865.2A patent/CN107325814B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN107325814A (en) | 2017-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107325814B (en) | A kind of fluorescence silicon nano dots and the preparation method and application thereof | |
Shen et al. | The production of pH-sensitive photoluminescent carbon nanoparticles by the carbonization of polyethylenimine and their use for bioimaging | |
Wang et al. | pH-sensitive and biodegradable charge-transfer nanocomplex for second near-infrared photoacoustic tumor imaging | |
Miao et al. | Papain-templated Cu nanoclusters: assaying and exhibiting dramatic antibacterial activity cooperating with H 2 O 2 | |
Kundu et al. | Facile approach to synthesize highly fluorescent multicolor emissive carbon dots via surface functionalization for cellular imaging | |
Kasibabu et al. | Imaging of bacterial and fungal cells using fluorescent carbon dots prepared from carica papaya juice | |
Tong et al. | Amorphous carbon dots with high two-photon fluorescence for cellular imaging passivated by hyperbranched poly (amino amine) | |
An et al. | An ultrasensitive turn-on ratiometric fluorescent probes for detection of Ag+ based on carbon dots/SiO2 and gold nanoclusters | |
Wang et al. | Glutathione modified carbon-dots: from aggregation-induced emission enhancement properties to a “turn-on” sensing of temperature/Fe 3+ ions in cells | |
Wei et al. | In situ crystal growth of gold nanocrystals on upconversion nanoparticles for synergistic chemo-photothermal therapy | |
Vijayakumar et al. | In vitro cytotoxicity assay on gold nanoparticles with different stabilizing agents | |
Pathak et al. | Multicolor emitting N/S-doped carbon dots as a fluorescent probe for imaging pathogenic bacteria and human buccal epithelial cells | |
Xiang et al. | A multifunctional nanoplatform for lysosome targeted delivery of nitric oxide and photothermal therapy under 808 nm near-infrared light | |
Kumar et al. | A hydrothermal reaction of an aqueous solution of BSA yields highly fluorescent N doped C-dots used for imaging of live mammalian cells | |
Na et al. | Synthesis of silicon nanoparticles emitting yellow-green fluorescence for visualization of pH change and determination of intracellular pH of living cells | |
Zhao et al. | A multifunctional nanoprobe for targeting tumors and mitochondria with singlet oxygen generation and monitoring mitochondrion pH changes in cancer cells by ratiometric fluorescence imaging | |
Wang et al. | CePO 4: Tb, Gd hollow nanospheres as peroxidase mimic and magnetic–fluorescent imaging agent | |
Zhu et al. | Photoluminescent graphene quantum dots for in vitro and in vivo bioimaging using long wavelength emission | |
Zhang et al. | Rapid microwave synthesis of N-doped carbon nanodots with high fluorescence brightness for cell imaging and sensitive detection of iron (III) | |
Luo et al. | Biocompatible perovskite quantum dots with superior water resistance enable long-term monitoring of the H 2 S level in vivo | |
Liu et al. | Design of a cellulose nanocrystal-based upconversion ratiometric fluorescent nanoprobe for pH monitoring and imaging | |
Meng et al. | A facile synthesis of long-wavelength emission nitrogen-doped carbon dots for intracellular pH variation and hypochlorite sensing | |
Zan et al. | One-step synthesis of green emission carbon dots for selective and sensitive detection of nitrite ions and cellular imaging application | |
Lakshmi et al. | Lanthanum mediated rutin yellow-fluorescent carbon dots as multifaceted sensing probes for the detection of calcium ions in melanoma and plant cells | |
Wang et al. | Multi-stable fluorescent silica nanoparticles obtained from in situ doping with aggregation-induced emission molecules |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |